Biologic treatments are your fourth modality in the treatment of cancer, after surgery, chemotherapy, and radiation. Biologic therapy produces anticancer effects through either those things of the natural immune defense system or by the administration of natural substances.
Biologic therapies for that treatment of cancer are known as biologic response modifier. These substances, that are naturally produced in small quantities in the body, is now able to produced in vast amounts through recombinant DNA technology. Some may function to enhance the host immune system to protect against foreign substances for example tumor cells.
With recent developments in hybridoma technology, researchers are now able to produce virtually unlimited levels of identical monoclonal antibodies by cloning these hybrid cells and looking after them indefinitely in tissue culture. Recombinant DNA techniques combine parts of the DNA of two or more different organisms, which may be induced in culture to create limitless levels of human proteins.
In by doing this, synthetic proteins just like those naturally sourced in limited quantities in the body is now able to reproduced in vast amounts. The introduction of hybridoma technology and recombinant DNA techniques has grown the use of BRMs in clinical use for that diagnosis and treatment of cancer.
The nation's Cancer Institute's Division of Cancer Treatment Subcommittee on Biological Response Modifiers has defined BRMs as agents or approaches that affect the relationship between host and tumor by changing the host's immune reaction to tumor cells, which ends in a therapeutic effect. BRMs include mAbs, cytokines, along with other biologic agents for example tumor necrosis factor. Many BRMs they are under investigation in many studies. The meals and Drug Administration has approved more than 25BRMs to be used in medical treatment.
You will find 3 ways in which BRMs function: by direct cytotoxic activity on tumor cells, by restoring, strengthening, or modulating the host's tumor-immune response, by modifying other biologic effects, for example by disturbing the tumor cell's survival and metastatic abilities.
Biologic therapy for cancer treatment could be split into active and passive approaches and additional subdivided into nonspecific and particular biotherapy. Active biotherapy tries to use substances that elicit an immune response able to eliminating or retarding tumor growth through immunization of cancer patients. Vaccines for example anti-idiotype mAbs are utilized to induce active specific immunity. Passive biotherapy uses substances that supplement components of the host's immune system. Passive specific biotherapy includes using mAbs; passive nonspecific biotherapy uses cytokines.
Our website is not responsible for the information contained by this article. Webworldarticles.com is a free articles resource thus practically any visitor can submit an article. However if you notice any copyrighted material, please contact us and we will remove the article(s) in discussion right away.
This article was sent to us by:
Norman Howell at
07252011
1. Hematopoietic growth factors and chemotherapy in cancer treatment
All articles in this directory are property of their respective authors. Additionally, read our Privacy Policy
© 2010 WebWorldarticles.com - All Rights Reserved. Partners: Gunblade Saga